16th Oct 2008 12:42
Dechra Pharmaceuticals PLC
(the Company)
Directors / PDMR Sharedealing
16 October 2008
Dechra Pharmaceuticals PLC announces that, on 15 October 2008, the following Directors and PDMR's exercised options over ordinary shares of 1p each in the Company, granted to them on 3 October 2005 pursuant to the Dechra Pharmaceuticals Plc Long Term Incentive Plan (the LTIP), at an exercise price of £1 each:
|
Name |
Capacity |
Options Exercised |
Shares Sold |
Sale Price per share |
Total beneficial shareholding following this announcement |
|
Ian Page |
Director |
34,861 |
14,337 |
£4.00 |
779,856 |
|
Simon Evans |
Director |
23,904 |
0 |
0 |
830,274 |
|
Edwin Torr |
Director |
22,908 |
9,421 |
£4.00 |
440,283 |
|
Giles Coley |
PDMR |
14,940 |
6,145 |
£4.00 |
83,269 |
|
Mike Annice |
PDMR |
18,426 |
7,578 |
£4.00 |
659,830 |
|
Peter Graham |
PDMR |
15,936 |
6,554 |
£4.00 |
55,302 |
|
Mike Eldred |
PDMR |
38,308 |
15,370 |
£4.00 |
22,938 |
The exercise of the LTIP options were subject to the achievement of performance conditions which were satisfied in full.
All Directors (other than Simon Evans) and PDMR's have sold sufficient shares (acquired pursuant to the LTIP exercise) in order to fund the resulting tax liability.
Enquiries:
Zoe Bamford
Company Secretary
01782 771100
Related Shares:
DPH.L